Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer

Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer

Epidermal Growth Factor Receptor (EGFR) is overexpressed on a number of human cancers, and often is indicative of a poor outcome. Treatment of EGFR/HER2 overexpressing cancers includes monoclonal antibody therapy (cetuximab/trastuzumab) either alone or in conjunction with other standard cancer thera...

Full description

Bibliographic Details
Main Authors: Hester A. Doyle, Renelle J. Gee, Tyler D. Masters, Christian R. Gee, Carmen J. Booth, Elizabeth Peterson-Roth, Raymond A. Koski, Stuart C. Helfand, Lauren Price, Deborah Bascombe, Dorothy Jackson, Rita Ho, Gerald R. Post, Mark J. Mamula
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Translational Oncology
Subjects:
EGFR
Vaccine
Peptide
Canine
Osteosarcoma
Abbreviations: BSA, bovine serum albumin
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523321001972

Internet

http://www.sciencedirect.com/science/article/pii/S1936523321001972

Similar Items